KRAS and rectal cancer: Regarding rectal cancer solely, this study is to our knowledge one of the largest cohort for the specific evaluation of intra- [12] and intertumoral KRAS mutation status heterogeneity in patients with locally advanced rectal cancer who were treated preoperatively with CRT within a clinical study setting.